Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients
Gibbons, S.; Grevel, J.; Reynolds, K.; Ried, M.; Rutzky, L.P.; Kahan, B.D.
Transplantation Proceedings 20(2 Suppl 2: 339-344
1988
ISSN/ISBN: 0041-1345 PMID: 3284077 Document Number: 325196
Document emailed within 1 workday
Related Documents
Heidecke, C.D.; Nicolaus, C.; Stadler, J.; Florack, G.; Bollschweiler, E.; Hölscher, M. 1987: Measurement of cyclosporine bioactivity in serum of renal transplant recipients: development and comparison with RIA Transplantation Proceedings 19(1 Part 2): 1734-1736Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Veremis, S.A.; Maddux, M.S.; Tang, I.Y.; Millner, S.N.; Prasad, R.; Pollak, R.; Mozes, M.F. 1989: Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection Transplantation Proceedings 21(1 Part 2): 1476-1477
Sumrani, N.; Delaney, V.; Ding, Z.; Davis, R.; Butt, K.; Hong, J. 1991: Is cyclosporine indicated in HLA-identical renal transplant recipients? Transplantation Proceedings 23(1 Part 2): 1239-1240
Ducloux, D.; Fournier, V.; Rebibou, J.M.; Bresson-Vautrin, C.; Gibey, R.; Chalopin, J.M. 1998: Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine Clinical Nephrology 49(4): 232-235
Duraj, F.F.; Bäckman, L.; Dati, F.; Ringdén, O. 1990: Monitoring low molecular weight serum proteins in cyclosporine A-treated bone marrow transplant recipients Transplantation Proceedings 22(1): 203-204
Laine, J.; Holmberg, C. 1996: Tubular effects of cyclosporine in pediatric renal transplant recipients Transplantation Proceedings 28(4): 2104-2106
Mihatsch, M.J.; Thiel, G.; Basler, V.; Ryffel, B.; Landmann, J.; von Overbeck, J.; Zollinger, H.U. 1985: Morphological patterns in cyclosporine-treated renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 101-116
Carmellini, M.; Romagnoli, J.; Pietrabissa, A.; Di Stefano, R.; Oleggini, M.; Rindi, P.; Rizzo, G.; Mosca, F. 1994: Evaluation of infections in renal transplant recipients treated with cyclosporine Transplantation Proceedings 26(5): 2658-2659
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
Kerman, R.H.; Van Buren, C.T.; Lewis, R.M.; Kahan, B.D. 1988: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients Transplantation Proceedings 20(3 Suppl 3: 264-269
Costa, C.; Sidoti, F.; Mantovani, S.; Gregori, G.; Proietti, A.; Ghisetti, V.; Cavallo, R. 2016: Comparison of two molecular assays for detection of cytomegalovirus DNA in whole blood and plasma samples from transplant recipients New Microbiologica 39(3): 186-191
Hughes, J.R.; Hughes, V.F.; Trull, A.K.; Metcalfe, S.M. 1999: Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine Transplantation 68(4): 583-586
Vilardell, J.; Oppenheimer, F.; Talbot-Wright, R.; Ricart, M.J.; Andreu, J.; Alcaraz, A.; Carretero, P. 1992: Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine Transplantation Proceedings 24(5): 1948
Ovuworie, C.A.; Fox, E.R.; Chow, C.M.; Pascual, M.; Shih, V.E.; Picard, M.H.; Tolkoff-Rubin, N.E. 2001: Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients Transplantation 72(8): 1385-1388
Keitel, E.; Bittar, A.E.; Losekann, A.; Deboni, L.; Ceretta, F.; Goldani, J.C.; Garcia, V.D. 1992: Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy Transplantation Proceedings 24(6): 2606-2608
Yoshimura, N.; Kahan, B.D.; Oka, T. 1991: The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 958-960
Smith, C.L.; Hampton, E.M.; Pederson, J.A.; Pennington, L.R.; Bourne, D.W. 1994: Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients PharmacoTherapy 14(4): 471-481
Salomon, D.; Brunson, M.; Vansickler, J.; Pfaff, W.; Howard, R.; Peterson, J.; Curry, T.; Thompson, R.; Squiers, E. 1991: A retrospective analysis of late renal graft function: correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity Transplantation Proceedings 23(1 Pt 2): 1018-1019